SFTPA1 | Surfactant protein A1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SFTPB | Surfactant protein B | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SFTPA2 | Surfactant protein A2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SFTPC | Surfactant protein C | Disease related genes
| | | | | Tissue enriched |
NKX2-1 | NK2 homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
SFTPD | Surfactant protein D | Predicted secreted proteins
| | | | | Tissue enriched |
CCDC37 | Coiled-coil domain containing 37 | | | | | | Group enriched |
DNAH12 | Dynein, axonemal, heavy chain 12 | Cancer-related genes
| | | | | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DLEC1 | Deleted in lung and esophageal cancer 1 | Disease related genes Plasma proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
NAPSA | Napsin A aspartic peptidase | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
UPK3B | Uroplakin 3B | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ICAM5 | Intercellular adhesion molecule 5, telencephalin | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SCGB1A1 | Secretoglobin, family 1A, member 1 (uteroglobin) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Transporters
| | | | | Tissue enriched |
LAMP3 | Lysosomal-associated membrane protein 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
TREM1 | Triggering receptor expressed on myeloid cells 1 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | | | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | | | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLEC14A | C-type lectin domain family 14, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
GGTLC3 | Gamma-glutamyltransferase light chain 3 | | | | | | Tissue enhanced |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | | | | | | Tissue enhanced |
LRRC36 | Leucine rich repeat containing 36 | | | | | | Tissue enhanced |
MARCO | Macrophage receptor with collagenous structure | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MSR1 | Macrophage scavenger receptor 1 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NDNF | Neuron-derived neurotrophic factor | Predicted secreted proteins
| | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PRX | Periaxin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
S100A3 | S100 calcium binding protein A3 | | | | | | Tissue enhanced |
SUSD2 | Sushi domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
TBX2 | T-box 2 | Transcription factors
| | | | | Tissue enhanced |
TMEM100 | Transmembrane protein 100 | Predicted membrane proteins
| | | | | Tissue enhanced |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |